Prudential Financial’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $679K | Buy |
46,980
+28,080
| +149% | +$403K | ﹤0.01% | 1750 |
|
|
2025
Q4 | $269K | Sell |
18,900
-18,174
| -49% | -$179K | ﹤0.01% | 2001 |
|
|
2025
Q3 | $292K | Sell |
37,074
-236,520
| -86% | -$1.68M | ﹤0.01% | 2101 |
|
|
2025
Q2 | $1.57M | Sell |
273,594
-154,355
| -36% | -$996K | ﹤0.01% | 1491 |
|
|
2025
Q1 | $3.49M | Sell |
427,949
-51,500
| -11% | -$477K | 0.01% | 1016 |
|
|
2024
Q4 | $4.52M | Buy |
479,449
+21,000
| +5% | +$218K | 0.01% | 919 |
|
|
2024
Q3 | $4.9M | Buy |
458,449
+45,280
| +11% | +$493K | 0.01% | 1006 |
|
|
2024
Q2 | $4.1M | Buy |
413,169
+299,635
| +264% | +$3.08M | 0.01% | 1019 |
|
|
2024
Q1 | $1.34M | Sell |
113,534
-182,685
| -62% | -$2.34M | ﹤0.01% | 1680 |
|
|
2023
Q4 | $4.2M | Sell |
296,219
-438,975
| -60% | -$4.98M | 0.01% | 1022 |
|
|
2023
Q3 | $8.94M | Sell |
735,194
-20,000
| -3% | -$258K | 0.01% | 674 |
|
|
2023
Q2 | $9.49M | Buy |
755,194
+21,410
| +3% | +$254K | 0.01% | 671 |
|
|
2023
Q1 | $8.14M | Buy |
733,784
+408,025
| +125% | +$5.03M | 0.01% | 707 |
|
|
2022
Q4 | $3.98M | Buy |
325,759
+150,985
| +86% | +$1.7M | 0.01% | 965 |
|
|
2022
Q3 | $1.82M | Buy |
174,774
+153,900
| +737% | +$1.71M | ﹤0.01% | 1380 |
|
|
2022
Q2 | $148K | Sell |
20,874
-163,820
| -89% | -$1.35M | ﹤0.01% | 2495 |
|
|
2022
Q1 | $1.75M | Sell |
184,694
-111,051
| -38% | -$1.04M | ﹤0.01% | 1574 |
|
|
2021
Q4 | $3.57M | Buy |
295,745
+75,047
| +34% | +$836K | ﹤0.01% | 1211 |
|
|
2021
Q3 | $2.11M | Sell |
220,698
-8,493
| -4% | -$86.9K | ﹤0.01% | 1438 |
|
|
2021
Q2 | $2.21M | Sell |
229,191
-4,930
| -2% | -$48.1K | ﹤0.01% | 1428 |
|
|
2021
Q1 | $2.31M | Buy |
234,121
+16,270
| +7% | +$252K | ﹤0.01% | 1384 |
|
|
2020
Q4 | $5.03M | Buy |
217,851
+55,758
| +34% | +$1.14M | 0.01% | 994 |
|
|
2020
Q3 | $2.29M | Buy |
162,093
+416
| +0.3% | +$6.06K | ﹤0.01% | 1273 |
|
|
2020
Q2 | $2.44M | Buy |
161,677
+686
| +0.4% | +$8.36K | ﹤0.01% | 1254 |
|
|
2020
Q1 | $1.49M | Sell |
160,991
-104,429
| -39% | -$993K | ﹤0.01% | 1510 |
|
|
2019
Q4 | $2.58M | Sell |
265,420
-353,758
| -57% | -$3.24M | ﹤0.01% | 1480 |
|
|
2019
Q3 | $4.99M | Buy |
619,178
+59,778
| +11% | +$649K | 0.01% | 1114 |
|
|
2019
Q2 | $6.98M | Buy |
559,400
+2,791
| +0.5% | +$35.4K | 0.01% | 1000 |
|
|
2019
Q1 | $7.57M | Sell |
556,609
-85,857
| -13% | -$1.05M | 0.01% | 961 |
|
|
2018
Q4 | $5.95M | Sell |
642,466
-44
| -0% | -$484 | 0.01% | 1021 |
|
|
2018
Q3 | $7.77M | Buy |
642,510
+103,550
| +19% | +$1.45M | 0.01% | 1013 |
|
|
2018
Q2 | $8.42M | Buy |
538,960
+23,640
| +5% | +$357K | 0.01% | 1009 |
|
|
2018
Q1 | $7.75M | Sell |
515,320
-84,290
| -14% | -$1.28M | 0.01% | 1012 |
|
|
2017
Q4 | $8.8M | Buy |
599,610
+131,710
| +28% | +$1.81M | 0.01% | 955 |
|
|
2017
Q3 | $7.06M | Sell |
467,900
-296,180
| -39% | -$3.92M | 0.01% | 1013 |
|
|
2017
Q2 | $7.69M | Sell |
764,080
-49,620
| -6% | -$399K | 0.01% | 981 |
|
|
2017
Q1 | $5.8M | Buy |
813,700
+211,200
| +35% | +$1.34M | 0.01% | 1067 |
|
|
2016
Q4 | $2.99M | Sell |
602,500
-152,200
| -20% | -$1.05M | ﹤0.01% | 1341 |
|
|
2016
Q3 | $5.58M | Sell |
754,700
-182,880
| -20% | -$1.24M | 0.01% | 1028 |
|
|
2016
Q2 | $5.12M | Buy |
937,580
+323,280
| +53% | +$2.26M | 0.01% | 1097 |
|
|
2016
Q1 | $5.19M | Sell |
614,300
-400
| -0.1% | -$2.83K | 0.01% | 1082 |
|
|
2015
Q4 | $5.96M | Buy |
614,700
+170,200
| +38% | +$1.53M | 0.01% | 1006 |
|
|
2015
Q3 | $6.22M | Buy |
+444,500
| New | +$6.97M | 0.01% | 932 |
|
|
2015
Q2 | – | Sell |
-50,385
| Closed | -$548K | – | 2238 |
|
|
2015
Q1 | $548K | Buy |
+50,385
| New | +$444K | ﹤0.01% | 1971 |
|
Other funds holding FOLD
VCM
PCM
VPM
GCL
Prudential Financial's FOLD Position: Q1 2026 in Review
Prudential Financial increased its Amicus Therapeutics (FOLD) stake by 149% in Q1 2026, buying an estimated $403K and bringing the position to 46,980 shares worth $679K. The position accounts for ﹤0.01% of the portfolio, ranked #1750.
Prudential Financial first reported a position in FOLD in Q1 2015 and has held it in 44 quarters since. The position peaked at $9.49M in Q2 2023. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.
- Prudential Financial held 46,980 shares of Amicus Therapeutics worth $679K as of Q1 2026.
- Prudential Financial bought 28,080 Amicus Therapeutics shares in Q1 2026, an estimated $403K.
- Amicus Therapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #1750 holding.
- Prudential Financial first reported a position in Amicus Therapeutics in Q1 2015 and has held it in 44 quarters since.
- Prudential Financial's Amicus Therapeutics position peaked at $9.49M in Q2 2023.
- 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.
Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.